Oncology
10 drugs are in development for Solid Tumor.
- Companies
- 5
- Clinical trials
- 100
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Solid Tumor pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(3)
| Drug | Company |
|---|---|
| tpst-2003 | Tempest Therapeutics, Inc. (TPST) |
| tpst-2206 | Tempest Therapeutics, Inc. (TPST) |
| tpst-3206 | Tempest Therapeutics, Inc. (TPST) |
Phase 1(3)
Preclinical(1)
| Drug | Company |
|---|---|
| tpst-3003 | Tempest Therapeutics, Inc. (TPST) |
Phase 1/Phase 2(2)
Phase 4(1)
| Drug | Company |
|---|---|
| Selpercatinib | ELI LILLY & Co (LLY) |
About this indication
Solid Tumor context
Oncology·MeSH: Neoplasms (D009369)
Narrower concept of MeSH descriptor Neoplasms
Compare drugs
Frequently asked questions
How many drugs are in development for Solid Tumor?
BioSniper tracks 10 drugs in development for Solid Tumor across 5 companies.
How many clinical trials target Solid Tumor?
There are 100 clinical trials targeting Solid Tumor tracked by BioSniper.